WallStreetZenWallStreetZen

NYSE: HCA
Hca Healthcare Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for HCA

Based on 13 analysts offering 12 month price targets for Hca Healthcare Inc.
Min Forecast
$254.00+1.41%
Avg Forecast
$288.00+14.98%
Max Forecast
$316.00+26.16%

Should I buy or sell HCA stock?

Based on 13 analysts offering ratings for Hca Healthcare Inc.
Strong Buy
Strong Buy
6 analysts 46.15%
Buy
4 analysts 30.77%
Hold
3 analysts 23.08%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their HCA stock forecasts and price targets.

HCA stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2023-11-17
lockedlocked$00.00+00.00%2023-11-10
lockedlocked$00.00+00.00%2023-10-30
lockedlocked$00.00+00.00%2023-10-26
lockedlocked$00.00+00.00%2023-10-25
Mizuho
Top 10%
91
Strong BuyMaintains$275.00+9.79%2023-10-25
RBC Capital
Top 27%
74
BuyMaintains$284.00+13.38%2023-10-25
Citigroup
Bottom 10%
10
Strong BuyMaintains$279.00+11.39%2023-10-25
Raymond James
Top 18%
83
BuyMaintains$280.00+11.79%2023-10-25
Cantor Fitzgerald
Bottom 11%
11
Strong BuyReiterates$315.00+25.76%2023-09-14

1 of 2

Forecast return on equity

Is HCA forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
30.08%

Forecast return on assets

Is HCA forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

HCA revenue forecast

What is HCA's revenue in the next 3 years based on estimates from 9 analysts?
Avg 1 year Forecast
$64.2B+1.66%
Avg 2 year Forecast
$67.5B+6.85%
Avg 3 year Forecast
$70.5B+11.56%
HCA's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

HCA earnings growth forecast

How is HCA forecast to perform vs Medical Care Facilities companies and vs the US market?
Company
5.05%
Industry
20.33%
Market
17.67%
HCA's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
HCA's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
HCA's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

HCA revenue growth forecast

How is HCA forecast to perform vs Medical Care Facilities companies and vs the US market?
Company
3.75%
Industry
4.74%
Market
7.51%
HCA's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
HCA's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

HCA vs Medical Care Facility Stocks

TickerPricePrice TargetUp/downsideConsensus
HCA$250.48$288.00+14.98%Strong Buy
FMS$20.51$24.00+17.02%Hold
UHS$137.48$156.25+13.65%Hold
DVA$101.46$108.50+6.94%Buy
CHE$567.00$597.00+5.29%Buy
View Top Medical Care Facility Stocks

Hca Healthcare Stock Forecast FAQ

Is Hca Healthcare Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 13 Wall Street analysts covering (NYSE: HCA) stock is to Strong Buy HCA stock.

Out of 13 analysts, 6 (46.15%) are recommending HCA as a Strong Buy, 4 (30.77%) are recommending HCA as a Buy, 3 (23.08%) are recommending HCA as a Hold, 0 (0%) are recommending HCA as a Sell, and 0 (0%) are recommending HCA as a Strong Sell.

If you're new to stock investing, here's how to buy Hca Healthcare stock.

What is HCA's revenue growth forecast for 2023-2025?

(NYSE: HCA) Hca Healthcare's forecast annual revenue growth rate of 3.75% is not forecast to beat the US Medical Care Facilities industry's average forecast revenue growth rate of 4.74%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 7.51%.

Hca Healthcare's revenue in 2023 is $63,162,000,000.On average, 9 Wall Street analysts forecast HCA's revenue for 2023 to be $17,187,099,260,531, with the lowest HCA revenue forecast at $17,136,374,059,341, and the highest HCA revenue forecast at $17,260,106,688,000. On average, 9 Wall Street analysts forecast HCA's revenue for 2024 to be $18,064,140,994,944, with the lowest HCA revenue forecast at $17,711,211,493,888, and the highest HCA revenue forecast at $18,297,412,735,360.

In 2025, HCA is forecast to generate $18,861,087,108,582 in revenue, with the lowest revenue forecast at $18,421,302,213,248 and the highest revenue forecast at $19,049,954,457,600.

What is HCA's forecast return on assets (ROA) for 2023-2026?

(NYSE: HCA) forecast ROA is N/A, which is lower than the forecast US Medical Care Facilities industry average of N/A.

What is HCA's Price Target?

According to 13 Wall Street analysts that have issued a 1 year HCA price target, the average HCA price target is $288.00, with the highest HCA stock price forecast at $316.00 and the lowest HCA stock price forecast at $254.00.

On average, Wall Street analysts predict that Hca Healthcare's share price could reach $288.00 by Nov 17, 2024. The average Hca Healthcare stock price prediction forecasts a potential upside of 14.98% from the current HCA share price of $250.48.

What is HCA's forecast return on equity (ROE) for 2023-2026?

(NYSE: HCA) forecast ROE is N/A, which is considered weak.
©2023 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.